Compare hormone-related identities, not class labels
A GHRH-related reference, a different secretagogue and an IGF-related analogue are not interchangeable purchasing options. CJC-1295 with DAC, without DAC and blends must remain separately identified even when listed together.
Make the comparison specific
Use a comparison sheet with full identity, salt, component ratio and actual finished-product record. A historic sermorelin name or a tesamorelin medicine's label cannot validate another preparation. Review FDA's compound-specific safety discussion where applicable.
Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.
Related guidance: Hormone clinic purchasing review. These references support a review, not a treatment recommendation or supply authorization.